These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24064185)

  • 21. PIN-1 promoter polymorphisms in mild cognitive impairment and susceptibility to Alzheimer's disease: a preliminary report.
    Arosio B; Segat L; Milanese M; Galimberti L; Calabresi C; Zanetti M; Trabattoni D; Annoni G; Crovella S; Vergani C
    Aging Clin Exp Res; 2007 Oct; 19(5):406-9. PubMed ID: 18007120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.
    Berchtold NC; Sabbagh MN; Beach TG; Kim RC; Cribbs DH; Cotman CW
    Neurobiol Aging; 2014 Sep; 35(9):1961-72. PubMed ID: 24786631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.
    Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Kenney AE; Gross CJ; Taub ES; Plassman BL; Fisher GG
    Neuropsychology; 2013 Jan; 27(1):86-94. PubMed ID: 23356599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UBQ-8i polymorphism is not an independent risk factor for mild cognitive impairment and Alzheimer's disease in APOE-4 carriers.
    Martin XE; Martinez MF; Fernandez DG; Busto FG; Alcelay LG; Ferreras MJC; Flores JC; Pancorbo MM
    Curr Alzheimer Res; 2012 May; 9(4):467-72. PubMed ID: 22272618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.
    Patel A; Rees SD; Kelly MA; Bain SC; Barnett AH; Prasher A; Arshad H; Prasher VP
    BMC Res Notes; 2014 Jan; 7():42. PubMed ID: 24438528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.
    Lunnon K; Ibrahim Z; Proitsi P; Lourdusamy A; Newhouse S; Sattlecker M; Furney S; Saleem M; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Coppola G; Geschwind D; Simmons A; Lovestone S; Dobson R; Hodges A;
    J Alzheimers Dis; 2012; 30(3):685-710. PubMed ID: 22466004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translating Alzheimer's disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs.
    Katsumata Y; Nelson PT; Estus S; ; Fardo DW
    Neurobiol Aging; 2019 Feb; 74():135-146. PubMed ID: 30448613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
    Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
    Hollingworth P; Harold D; Sims R; Gerrish A; Lambert JC; Carrasquillo MM; Abraham R; Hamshere ML; Pahwa JS; Moskvina V; Dowzell K; Jones N; Stretton A; Thomas C; Richards A; Ivanov D; Widdowson C; Chapman J; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Holmes C; Mann D; Smith AD; Beaumont H; Warden D; Wilcock G; Love S; Kehoe PG; Hooper NM; Vardy ER; Hardy J; Mead S; Fox NC; Rossor M; Collinge J; Maier W; Jessen F; Rüther E; Schürmann B; Heun R; Kölsch H; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Gallacher J; Hüll M; Rujescu D; Giegling I; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Sleegers K; Bettens K; Engelborghs S; De Deyn PP; Van Broeckhoven C; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Pankratz VS; Sando SB; Aasly JO; Barcikowska M; Wszolek ZK; Dickson DW; Graff-Radford NR; Petersen RC; ; van Duijn CM; Breteler MM; Ikram MA; DeStefano AL; Fitzpatrick AL; Lopez O; Launer LJ; Seshadri S; ; Berr C; Campion D; Epelbaum J; Dartigues JF; Tzourio C; Alpérovitch A; Lathrop M; ; Feulner TM; Friedrich P; Riehle C; Krawczak M; Schreiber S; Mayhaus M; Nicolhaus S; Wagenpfeil S; Steinberg S; Stefansson H; Stefansson K; Snaedal J; Björnsson S; Jonsson PV; Chouraki V; Genier-Boley B; Hiltunen M; Soininen H; Combarros O; Zelenika D; Delepine M; Bullido MJ; Pasquier F; Mateo I; Frank-Garcia A; Porcellini E; Hanon O; Coto E; Alvarez V; Bosco P; Siciliano G; Mancuso M; Panza F; Solfrizzi V; Nacmias B; Sorbi S; Bossù P; Piccardi P; Arosio B; Annoni G; Seripa D; Pilotto A; Scarpini E; Galimberti D; Brice A; Hannequin D; Licastro F; Jones L; Holmans PA; Jonsson T; Riemenschneider M; Morgan K; Younkin SG; Owen MJ; O'Donovan M; Amouyel P; Williams J
    Nat Genet; 2011 May; 43(5):429-35. PubMed ID: 21460840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort.
    Guerreiro RJ; Bras JM; Santana I; Januario C; Santiago B; Morgadinho AS; Ribeiro MH; Hardy J; Singleton A; Oliveira C
    BMC Neurol; 2006 Jul; 6():24. PubMed ID: 16824219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Shanghai Aging Study.
    Xi J; Ding D; Zhao Q; Liang X; Zheng L; Guo Q; Hong Z; Fu H; Xu J; Xiao Q
    Curr Alzheimer Res; 2020; 17(2):185-195. PubMed ID: 32183673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial genes are altered in blood early in Alzheimer's disease.
    Lunnon K; Keohane A; Pidsley R; Newhouse S; Riddoch-Contreras J; Thubron EB; Devall M; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Schalkwyk L; Dobson R; Malik AN; Powell J; Lovestone S; Hodges A;
    Neurobiol Aging; 2017 May; 53():36-47. PubMed ID: 28208064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
    Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.
    Leduc V; De Beaumont L; Théroux L; Dea D; Aisen P; Petersen RC; ; Dufour R; Poirier J
    Mol Psychiatry; 2015 Jul; 20(7):867-73. PubMed ID: 25023145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    Cardoso R; Lemos C; Oliveiros B; Almeida MR; Baldeiras I; Pereira CF; Santos A; Duro D; Vieira D; Santana I; Oliveira CR
    J Alzheimers Dis; 2020; 78(2):587-601. PubMed ID: 33016906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updated Meta-Analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 Variants in Alzheimer's Disease.
    Almeida JFF; Dos Santos LR; Trancozo M; de Paula F
    J Mol Neurosci; 2018 Mar; 64(3):471-477. PubMed ID: 29504051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.
    Lanni C; Garbin G; Lisa A; Biundo F; Ranzenigo A; Sinforiani E; Cuzzoni G; Govoni S; Ranzani GN; Racchi M
    J Alzheimers Dis; 2012; 32(4):919-26. PubMed ID: 22890094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    Gabriel AJ; Almeida MR; Ribeiro MH; Carneiro D; Valério D; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    J Alzheimers Dis; 2018; 61(3):1097-1105. PubMed ID: 29254094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.
    Teixeira AL; Diniz BS; Campos AC; Miranda AS; Rocha NP; Talib LL; Gattaz WF; Forlenza OV
    Neuromolecular Med; 2013 Mar; 15(1):115-21. PubMed ID: 23055000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study.
    Swaminathan S; Shen L; Kim S; Inlow M; West JD; Faber KM; Foroud T; Mayeux R; Saykin AJ; ;
    Curr Alzheimer Res; 2012 Sep; 9(7):801-14. PubMed ID: 22486522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.